Alzheimer’s to Benefit from Landmark MRC-AstraZeneca Compound Collaboration

News   Nov 06, 2012

 
Alzheimer’s to Benefit from Landmark MRC-AstraZeneca Compound Collaboration
 
 
 

RELATED ARTICLES

Commonly Prescribed Painkillers: What Can be Done to Reduce Risk of Obesity and Sleep Deprivation?

News

Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.

READ MORE

Malvern Panalytical Wins Innovate UK Grant

News

Funding for 3-year-long project to lead biopharmaceutical consortium on aggregation analytics.

READ MORE

Beactica Awarded Funding to Develop New Therapeutics Against Aggressive Brain Tumours

News

Beactica announce funding for LSD1 programme for glioblastoma treatment.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE